blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2532740

EP2532740 - Antigen-specific CD4+ and CD8+ central-memory T cell preparations for adoptive T cell therapy [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  08.11.2013
Database last updated on 11.05.2024
Most recent event   Tooltip08.11.2013Application deemed to be withdrawnpublished on 11.12.2013  [2013/50]
Applicant(s)For all designated states
Schmück, Michael
Thaerstrasse 18
10249 Berlin / DE
For all designated states
Reinke, Petra
Hegelplatz 1
10117 Berlin / DE
For all designated states
Volk, Hans-Dieter
Hegelplatz 1
10117 Berlin / DE
[2012/50]
Inventor(s)01 / see applicant
...
 [2012/50]
Representative(s)Schulz Junghans Patentanwälte PartGmbB
Grossbeerenstrasse 71
10963 Berlin / DE
[N/P]
Former [2012/50]Schulz Junghans
Chausseestrasse 5
10115 Berlin / DE
Application number, filing date11177524.312.08.2011
[2012/50]
Priority number, dateEP2011016965511.06.2011         Original published format: EP 11169655
[2013/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2532740
Date:12.12.2012
Language:EN
[2012/50]
Search report(s)(Supplementary) European search report - dispatched on:EP19.09.2012
ClassificationIPC:C12N5/0783
[2012/50]
CPC:
C12N5/0636 (EP,US); A61K35/26 (US); A61K35/17 (US);
A61K39/4611 (EP); A61K39/464453 (EP); A61K39/464456 (EP);
A61K39/464486 (EP); A61K39/464838 (EP); C12N2501/2302 (EP,US);
C12N2501/2307 (EP,US); C12N2501/727 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/50]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:Antigenspezifische CD4+ und CD8+ zentrale Gedächtnis-T-Zellpräparate für adoptive T-Zelltherapie[2012/50]
English:Antigen-specific CD4+ and CD8+ central-memory T cell preparations for adoptive T cell therapy[2012/50]
French:Préparations de lymphocytes T à mémoire centrale CD4+ et CD8+ spécifiques aux antigènes pour thérapie de lymphocyte T adoptif[2012/50]
Examination procedure13.06.2013Application deemed to be withdrawn, date of legal effect  [2013/50]
24.07.2013Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2013/50]
Fees paidPenalty fee
Additional fee for renewal fee
31.08.201303   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XD]WO2009053109  (LETSCH ANNE [DE], et al) [XD] 6-12 * figures 4, 5 ** claims 7-10 *;
 [X]WO2010151517  (UNIV MICHIGAN [US], et al) [X] 1,2,4-12 * examples 1,2 * * claims 1-23 *;
 [X]  - SHAN HE ET AL, "Characterization of the Metabolic Phenotype of Rapamycin-Treated CD8+ T Cells with Augmented Ability to Generate Long-Lasting Memory Cells", PLOS ONE, (20110517), vol. 6, no. 5, doi:10.1371/journal.pone.0020107, page E20107, XP055026296 [X] 1,2,4-12 * the whole document *

DOI:   http://dx.doi.org/10.1371/journal.pone.0020107
by applicantUS3929992
 US4316885
 US4650803
 US5023264
 US5023263
 US5100883
 US5118677
 US5118678
 US5120842
 US5130307
 US5162333
 US5177203
 US5221670
 US5233036
 US5256790
 US5258389
 US5260300
 US5262423
 US5302584
 US5362718
 US5373014
 US5378836
 US5385908
 US5385909
 US5385910
 US5389639
 US5391730
 US5411967
 US5434260
 US5463048
 US5480988
 US5480989
 US5489680
 US5491231
 US5504091
 US5514213
 US5563145
 US5665772
 US5780462
 EP1257290
 WO2009053109
    - HAMMER ET AL., EUR. J. IMMUNOL., (2005), vol. 35, pages 2250 - 2258
    - BECKER ET AL., NAT. MED., (2001), vol. 7, pages 1159 - 62
    - F. HERMANS ET AL., JOURNAL OF IMMUNOLOGICAL METHODS, (20040201), vol. 285, no. 25
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.